Traditional chemotherapy wastes 95% of its dose on healthy cells, causing hair loss and organ damage. Precision oncology uses data to target cancer's molecular weak spots with micro-doses, often just 10-12% of conventional amounts, that work better with far fewer side effects.
So what's really exciting now is we can customize care. We don't have to worry. Oh, is natural medicine work or is this the right conventional target? No, the data guides us. We're totally unbiased. We let the data guide. But then there's another piece to this. It's how we're delivering treatment. If you think about it for a minute and you give IV chemotherapy, some of you may not know this. Only 5% actually makes it to the tumor, which means 95% is harming your nervous system, organs, losing hair, looking tired, run down. You can see this. If you've ever been to a cancer ward in a hospital, you. It is what you're seeing with over treatment, maximum therapeutic dose, sometimes increasing resistance. But when we know what the targets are, we can give really micro doses, maybe 10%, 12%. And those doses are so micro that you metabolize them well, but you also get the response that you want. Because we took the guesswork out, we're using the data to guide. This is the difference between precision targeting and conventional care.
